About Nausicaa Ventures
Nausicaa Ventures is a venture capital firm founded in 2009. It is primarily based out of Louvain la Neuve, Belgium. As of Dec 2017, Nausicaa Ventures has invested in 5 companies. It primarily invests in Series A round in Belgium based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series C round of NGDATA Overall, Nausicaa Ventures portfolio has seen 1 IPO, namely Bone Therapeutics. A lot of funds co-invest with Nausicaa Ventures, with names like Equitis sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 1 more
Portfolio IPOs
Portfolio Soonicorns
Nausicaa Ventures' List of All Investments
Nausicaa Ventures has a portfolio of 5 companies. Their most notable investments are in Bio-Sourcing and Mutracx.Their portfolio spans across Belgium and Netherlands. They have invested in Life Sciences, Enterprise Applications, HealthTech and 2 other sectors, across stages such as Series A, Series B and 1 more. Here is the list of all investments by Nausicaa Ventures:
1. Bio-Sourcing
Bio-sourcing is a manufacturer and supplier of biopharmaceuticals for animals. It has also partnered with multiple animal health companies to convert human therapeutic solutions into animal biological drugs.
Key facts about Bio-Sourcing
- Founded Year: 2014
- Location: Liege (Belgium)
- Stage: Series A
- Total Funding till date: $17.4M
- Employee Count: 14 as on Jul 01, 2024
- Investors: Equitis, Nausicaa Ventures and 3 Others
- Latest Funding Round: Series A, Sep 24, 2024, $*****
- Highlight: Editors' Pick
2. Ovizio
Developer of an imaging system for microscopes. The company has developed machine-learning software and microscopes. It has developed an AI-based software called OsOne which can provide the 3D analysis of images and continuous data recording among others. Its microscopic products are iLine F, QMode, I Line engineering platform among others.
Key facts about Ovizio
- Founded Year: 2009
- Location: Brussels (Belgium)
- Stage: Series A
- Total Funding till date: $9.34M
- Employee Count: 16 as on Dec 31, 2022
- Investors: New Science Ventures, Theodorus and 6 Others
- Latest Funding Round: Grant (prize money), Jun 30, 2017, $*****
- Highlight: Editors' Pick
3. NGDATA
AI based customer data platform for customer intelligence and delivering customized customer experience. NG data platform connects data sources containing customer interaction data and provides insights into this data using machine learning. Companies can use this data to personalize experiences for customers on channels. Some of the customers include Johnson and Johnson, ING, AXA, and Toyota.
Key facts about NGDATA
- Founded Year: 2012
- Location: Gentbrugge (Belgium)
- Stage: Series C
- Total Funding till date: $44.4M
- Employee Count: 58 as on Feb 28, 2026
- Investors: Capricorn Partners, HPE Growth and 8 Others
- Latest Funding Round: Series C, Dec 05, 2017, $*****
- Highlight: Editors' Pick
Developer of cell therapy products for orthopedics and bone diseases. The company's lead candidate drug is JTA-004 which targets 3 bone indications. Other products include ALLOB an allogeneic cell therapy for fractures and spinal fusion and BT-20 for inflammation.
Key facts about Bone Therapeutics
- Founded Year: 2006
- Location: Charleroi (Belgium)
- Stage: Public
- Total Funding till date: $17.9M
- Employee Count: 20 as on Dec 31, 2021
- Investors: SFPI, Life Sciences Research Partners and 5 Others
- Latest Funding Round: Post IPO, Apr 12, 2022, $*****
- Highlight: Public
_1575361128577.png?format=webp&height=120&width=120)
5. Mutracx
Key facts about Mutracx
- Founded Year: 2008
- Location: Nuenen (Netherlands)
- Stage: Deadpooled
- Total Funding till date: $8M
- Employee Count: 11 - 50 as on Jul 01, 2024
- Investors: Nausicaa Ventures and BOM
- Latest Funding Round: Series A, Feb 13, 2013, $*****
Nausicaa Ventures' Investments by Stage
Nausicaa Ventures has made 3 investments in Series A stage with an average round size of $7.78M, 1 investment in Series B stage with an average round size of $10.2M and 1 investment in Series D stage with an average round size of $10.4M.Stage of entry | No. of Investments |
|---|---|
Series A | 3 |
Series B | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
Nausicaa Ventures' Investments by Sector
Nausicaa Ventures has a diverse portfolio, with companies operating in the Life Sciences, Big Data - Industry Applications, Enterprise Applications, Food and Agriculture Tech and HealthTech. Notably, it has invested in 4 Enterprise (B2B) companies, 4 Tech companies, 2 Software companies and 1 company focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
Big Data - Industry Applications | 1 |
Enterprise Applications | 1 |
Food and Agriculture Tech | 1 |
HealthTech | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Nausicaa Ventures' Investments by Geography
Nausicaa Ventures has made most investments in Belgium (4), followed by Netherlands where it has made 1 investment.Country | No. of Investments |
|---|---|
Belgium | 4 |
Netherlands | 1 |
Note: We have considered here, only first round of investments
Nausicaa Ventures' recent investments
Nausicaa Ventures has not made any investment in 2026 so far.Here are the most recent investments by Nausicaa Ventures:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 05, 2017 | Belgium | Series C | 5301 | [+4] | |
Jan 05, 2017 | Belgium | Series B | 3383 | [+3] | |
Nov 16, 2015 | Belgium | Series A | 8575 | [+2] | |
Oct 28, 2015 | Belgium | Series B | 7326 | [+3] | |
Nov 07, 2014 | Belgium | Series A | 2265 | [+2] |
IPOs and Publicly Listed companies in Nausicaa Ventures' Portfolio
1 of Nausicaa Ventures' portfolio company became public - Bone Therapeutics. It got listed on the Euronext Exchange (Euronext), in Feb 2015 at marketcap of undefinedHere are Nausicaa Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 06, 2015 | Jan 28, 2013 | Series D | 7744 |
Co-investors of Nausicaa Ventures
Over the past 13 years, 23 investors have co-invested in Nausicaa Ventures's portfolio companies. This includes only funds.
- Invested before Nausicaa Ventures: Finnance.brussels, Capricorn Partners and 3 others have invested in rounds before Nausicaa Ventures. There is 1 company where Finnance.brussels has invested before Nausicaa Ventures and 1 company where Capricorn Partners has invested before Nausicaa Ventures.
- Top Co-investors of Nausicaa Ventures: 13 investors entered a company along with Nausicaa Ventures. These include investors like Equitis (1 company).
- Invested after Nausicaa Ventures: A total of 5 investors have invested in Nausicaa Ventures's portfolio after their investments. Top Investors include Europa (2 companies), EIC Fund (1 company) and HPE Growth (1 company).
Recent News related to Nausicaa Ventures
•
NGDATA Raises $19 Million to Fuel Global GrowthBusiness Wire•Dec 05, 2017•NGDATA, HPE Growth Capital, Idinvest Partners, Pamica and 3 others
•
Ovizio Imaging Systems Secures €8M Funding Round |FinSMEsFinSMEs•Nov 16, 2015•Ovizio, New Science Ventures, Qbic Fund, Nausicaa Ventures and 1 other
•
NGDATA Closes $10.2 M Funding Round to Broaden Adoption of Data-Driven Customer Experience Management Solution | Business WireBusiness Wire•Oct 28, 2015•NGDATA, Idinvest Partners, Capricorn Partners, Nausicaa Ventures and 2 others
•
NGDATA Closes $10.2M Series B Venture Capital Funding |FinSMEsFinSMEs•Oct 28, 2015•NGDATA, Idinvest Partners, Capricorn Partners, Nausicaa Ventures and 2 others
•
Merodis successfully advises BioSourcing for its capital increaseMerodis•Nov 07, 2014•Bio-Sourcing, Merodis, Nausicaa Ventures, Equitis and 2 others
•